The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term bisphosphonate therapy in bone metastatic breast cancer patients.
Berna Oksuzoglu
No relevant relationships to disclose
Oznur Bal
No relevant relationships to disclose
Ummugul Uyeturk
No relevant relationships to disclose
Ayse Demirci
No relevant relationships to disclose
Ayse Durnali
No relevant relationships to disclose
Ibrahim Turker
No relevant relationships to disclose
Necati Alkis
No relevant relationships to disclose